Sign in
4

Changes in Ownership

Alzamend Neuro, Inc. Filed Acc 0001214659-25-014629

Director sold 123,366 shares at an average $2.41 ($296,789)

  • Director acquired 100,000 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

AULT MILTON C III · Director

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2025-10-01 Conversion : show line 1 in the form +100,000 $2.32 $232,000 131,626 I
2025-10-01 Sale : show line 2 in the form −36,777 $2.35 $86,378 94,849 I
2025-10-02 Sale : show line 3 in the form −20,686 $2.39 $49,522 74,163 I
2025-10-03 Sale : show line 4 in the form −65,903 $2.44 $160,889 8,260 I
Open-market sales · 123,366 sh · avg $2.41 · $296,789

Table II: Derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2025-10-01 Conversion : show line 5 in the form Series B Convertible Preferred Stock −232 $1,000.00 $232,000 607.24 I
Loading xslF345X05/marketforms-70943.xml…